1. Home
  2. UK vs VRAX Comparison

UK vs VRAX Comparison

Compare UK & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ucommune International Ltd

UK

Ucommune International Ltd

HOLD

Current Price

$1.78

Market Cap

1.3M

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

BUY

Current Price

$1.36

Market Cap

1.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
UK
VRAX
Founded
2015
2013
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3M
1.5M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
UK
VRAX
Price
$1.78
$1.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.5K
★ 151.8K
Earning Date
11-03-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.10
52 Week High
$5.90
$13.19

Technical Indicators

Market Signals
Indicator
UK
VRAX
Relative Strength Index (RSI) 42.05 24.02
Support Level $1.63 $0.16
Resistance Level $2.22 $3.01
Average True Range (ATR) 0.19 0.28
MACD -0.01 -0.06
Stochastic Oscillator 36.76 1.53

Price Performance

Historical Comparison
UK
VRAX

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has two operating segments: Workspace membership, and Other services. The Workspace membership segment generates the majority of the company's revenue.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: